A Phase I/II Study of Concurrent Pemetrexed/Cisplatin/Radiation in Stage IIIA/B Non-Small Cell Lung Cancer
The purpose of this study is to determine the safety and efficacy of the combination of
pemetrexed and cisplatin given concurrently with high dose radiation treatment in patients
with unresectable but potentially curable stage IIIA/B non-small cell lung cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society